Ashkan Emadi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML) (NCT02283190) | Ashkan Emadi | 2014-04-01 |
Track Ashkan Emadi automatically
Every clearance here is in the API, with alerts when new ones post.